77087-60-6

Basic information

• Product Name: 3-[[(1,1-Dimethylethoxy)carbonyl]amino]-L-alanine methyl ester
• Synonyms: H-Dap(Boc)-OMe;3-[[(1,1-DIMETHYLETHOXY)CARBONYL]AMINO]-L-ALANINE METHYL ESTER;(S)-methyl 2-amino-3-N-Boc-propanoate;H-L-Dap(Boc)-OMe;(2S)-2-AMino-3-[(tert-butoxycarbonyl)aMino]propionic Acid Methyl Ester;3-[[(1,1-DiMethylethoxy)carbonyl]aMino]-L-alanine Ethyl Ester;(S)-Methyl 2-aMino-3-((tert-butoxycarbonyl)aMino)propanoate;(R)-ethyl 2-aMino-3-((tert-butoxycarbonyl)aMino)propanoate
• CAS NO: 77087-60-6
• Molecular Formula: C₉H₁₈N₂O₄
• Molecular Weight: 218.25
• Product Categories: Amino Acids & Derivatives
• Mol File: 77087-60-6.mol
• Article Data: 21

Chemical Properties

• Boiling Point: 325.7 °C at 760 mmHg
• Flash Point: 150.8 °C
• Appearance: /
• Density: 1.107 g/cm³
• Vapor Pressure: 0.000227mmHg at 25°C
• Refractive Index: 1.463
• Storage Temp.: Keep in dark place,Inert atmosphere,Store in freezer, under -20°C
• PKA: 11.95±0.46(Predicted)
• CAS DataBase Reference: 3-[[(1,1-Dimethylethoxy)carbonyl]amino]-L-alanine methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: 3-[[(1,1-Dimethylethoxy)carbonyl]amino]-L-alanine methyl ester(77087-60-6)
• EPA Substance Registry System: 3-[[(1,1-Dimethylethoxy)carbonyl]amino]-L-alanine methyl ester(77087-60-6)

Safety Data

• Hazardous Substances Data: 77087-60-6(Hazardous Substances Data)

Usage

Uses

Methyl 3-[t-Butyloxycarbonyl)amino]-L-alanine (cas# 77087-60-6) is a compound useful in organic synthesis.

InChI:InChI=1/C9H18N2O4/c1-9(2,3)15-8(13)11-5-6(10)7(12)14-4/h6H,5,10H2,1-4H3,(H,11,13)/t6-/m0/s1

Upstream product

• 20610-20-2 2,3-Diaminopropionic acid methyl ester 
• 24424-99-5 di-tert-butyl dicarbonate 
• 18635-45-5 D,L-α,β-diaminopropionic acid monohydrobromide 
• 6059-44-5 (L)-2,3-diaminopropionic acid methyl ester dihydrochloride 
• 58457-98-0 methyl (2S)-2-{[(benzyloxy)carbonyl]amino}-3-[(tert-butoxycarbonyl)amino]propanoate 
• 74536-29-1 (S)-2-amino-3-((tert-butoxycarbonyl)amino)propanoic acid 
• 16947-86-7 N^α-Tosyl-N^β-(tert-butpxycarbonyl)-L-α,β-diamonopropionic acid 
• 16947-84-5 N-[(benzyloxy)carbonyl]-3-[(tert-butoxycarbonyl)amino]-L-alanine 
• 1070-19-5 N-(tert-butyloxycarbonyl) azide 
• 162558-25-0 N-α-tert-butoxycarbonyl-N-β-(9-fluorenylmethoxycarbonyl)-L-diaminopropionic acid 
• 126046-25-1 (S)-3-Benzyloxycarbonyl-4-<(N-tert-butoxycarbonyl)aminomethyl>-5-oxazolidinone 

Downstream Products

• 197092-14-1 3-tert-butoxycarbonylamino-2-(toluene-3-sulfonylamino)-propionic acid methyl ester 
• 721927-33-9 benzyl (1S)-1-{[(tert-butoxycarbonyl)amino]methyl}-2-(dimethylamino)-2-oxoethylcarbamate 
• 1003577-88-5 (S)-methyl 3-[(tert-butoxycarbonyl)amino]-N-[(4-ethoxyphenyl)carbonyl]alaninate 
• 1265877-24-4 (S)-methyl 3-((tert-butoxycarbonyl)amino)-2-(((S)-1-phenylallyl)amino)propanoate 
• 1384613-21-1 C₁₆H₂₃N₃O₈S 
• 1384613-17-5 C₁₅H₂₁N₃O₈S 
• 1003579-30-3 (S)-methyl 3-[(tert-butoxycarbonyl)amino]-N-{[1-phenyl-3-(trifluoromethyl)-1H-pyrazol-4-yl]carbonyl}alaninate 
• 77087-65-1 (S)-2-({(R)-1-[(S)-2-(2-Benzyloxycarbonylamino-acetylamino)-3-phenyl-propionyl]-pyrrolidine-2-carbonyl}-amino)-3-tert-butoxycarbonylamino-propionic acid 2,4,5-trichloro-phenyl ester 

Relevant articles and documents

NOVEL IMIDAZOPYRAZINE DERIVATIVES

The invention provides novel imidazopyrazine derivatives having the general formula (I), wherein Rx and R3 to R5 are as described herein (formula (I)) or pharmaceutically acceptable salts thereof. Further provided are pharmaceutical compositions including the compounds, processes of manufacturing the compounds and methods of using the compounds as medicaments, in particular methods of using the compounds as antibiotics for the treatment or prevention of bacterial infections and resulting diseases.

LABELLED COMPOUNDS THAT BIND TO ALPHA-V-BETA-3 INTEGRIN

The present invention concerns in vivo imaging and in particular a novel in vivo imaging agent of formula (I). Also provided by the present invention is a method for the preparation of the in vivo imaging agent of the invention, and precursor compounds useful in said method. The in vivo imaging agent of the invention is useful in the diagnosis of conditions where there is a deviation from normal in the expression of integrin αvβ3.

Hydantoin and thiohydantoin derivatives as antiviral drugs

The present invention relates to a compound of the following formula (I), or a salt, solvate, tautomer, enantiomer, diastereoisomer or racemic mixture thereof: as well as its use as a drug, notably in the treatment of hepatitis C, its preparation process, and the pharmaceutical compositions containing such a compound.